1. Home
  2. ACET vs FRD Comparison

ACET vs FRD Comparison

Compare ACET & FRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$0.52

Market Cap

71.3M

Sector

Health Care

ML Signal

HOLD

Logo Friedman Industries Inc.

FRD

Friedman Industries Inc.

N/A

Current Price

$20.67

Market Cap

139.3M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ACET
FRD
Founded
1947
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Steel/Iron Ore
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
71.3M
139.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACET
FRD
Price
$0.52
$20.67
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
2.9M
22.3K
Earning Date
11-05-2025
02-06-2026
Dividend Yield
N/A
0.77%
EPS Growth
N/A
43.48
EPS
N/A
1.63
Revenue
N/A
$510,450,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$12.68
Revenue Growth
N/A
8.72
52 Week Low
$0.45
$12.24
52 Week High
$1.11
$23.50

Technical Indicators

Market Signals
Indicator
ACET
FRD
Relative Strength Index (RSI) 43.00 54.84
Support Level $0.47 $20.40
Resistance Level $0.52 $21.79
Average True Range (ATR) 0.04 0.76
MACD 0.01 0.11
Stochastic Oscillator 45.30 75.23

Price Performance

Historical Comparison
ACET
FRD

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About FRD Friedman Industries Inc.

Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.

Share on Social Networks: